Overview

Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients

Status:
Recruiting
Trial end date:
2022-10-31
Target enrollment:
Participant gender:
Summary
This phase 2 trial studies the effect of intravenous (IV) vitamin C repletion after myeloablative allogeneic stem cell transplant.
Phase:
Phase 2
Details
Lead Sponsor:
Virginia Commonwealth University
Treatments:
Ascorbic Acid
Vitamins